BU-CTSI 12th Annual Symposium Looks at AI and Its Impact on Translational Science
Artificial intelligence is a powerful, but still imperfect, tool.
Artificial intelligence is a powerful, but still imperfect, tool.
According to an editorial in the journal Critical Care Medicine, in the coming years, artificial intelligence (AI) should be part of the future of peer review.
The Edward Avedisian Professor and chair of pharmacology, physiology & biophysics, received a one-year, $100,000 grant from the Brain & Behavior Research Foundation (BBRF).
Research has demonstrated that digital voice measures can detect early signs of cognitive decline.
May improve overall survival rates, reduce unnecessary risks.
Historically, women have been underrepresented in health studies.
Highlights the need for special consideration for patients at higher risk for brain metastasis to be monitored and treated differently than most breast cancer patients.
Ability to detect changes earlier may empower individuals to take action and prevent decline.
The six-year contract covers operation and research adding to the study’s 77 years of research to date, and its legacy as the longest, continuous cohort study in the U.S.
Recommendations have implications for clinical practice, patient safety, and a healthy work environment for staff